Affinity Capture Purification Solutions For Novel Antibody Modalities

The structural diversity of Monoclonal antibodies (mAbs) and antibody-derived therapeutics demand advanced purification strategies. Traditional Protein A resins remain essential, yet novel formats—such as Fab fragments, Fc-fusion proteins, and bispecific antibodies—require specialized affinity solutions. This poster explores affinity resins engineered to enhance purification efficiency, yield, and scalability across various antibody modalities.

High-capacity Protein A resins enable robust purification for mAbs with intact binding sites, while affinity matrices targeting Fab fragments or Fc-fusion proteins ensure selective capture and high purity. Additionally, solutions designed for bispecific antibodies address unique purification challenges, facilitating efficient processing at mild pH conditions.

By leveraging these tailored affinity capture technologies, researchers and manufacturers can streamline workflows, improve product consistency, and maximize recovery. Whether refining established monoclonal antibody purification methods or optimizing emerging therapeutic formats, these solutions support scalable, high-performance purification.

Explore how next-generation affinity resins can meet the evolving demands of antibody purification in research and manufacturing settings.

_{For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.}